Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

COX-2 inhibitors for colorectal cancer

COX-2 selective non-steroidal anti-inflammatory drugs show promise in the prevention of coiorectal cancer and possibly other tumors.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Shift, S.J. & Rigas, B. Nonsteroidal antiinflamma-tory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology 113 1992–1998 (1997).

    Article  Google Scholar 

  2. Kawamori, T., Rao, C.V., Seibert, K. & Reddy, B.S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 58, 409–412 (1998).

    CAS  PubMed  Google Scholar 

  3. Williams, C.S. & DuBois, R.N. Prostaglandin endoperoxide synthase: Why two isoforms? Am. J. Physiol 270, G393–G400 (1996).

    CAS  PubMed  Google Scholar 

  4. Oshima, M. et al. Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803–809 (1996).

    Article  CAS  Google Scholar 

  5. Sheng, H., Shao, J., Morrow, J.D., Beauchamp, R.D. & DuBois, R.N. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 58, 362–366 (1998).

    CAS  PubMed  Google Scholar 

  6. Chan, T.A., Morin, P.J., Vogelstein, B. & Kinzler, K.W. Mechanisms underlying nonsteroidal anti-inflammatory drug-mediated apoptosis. Proc. Natl. Acad. Sci. USA 95, 681–686 (1998).

    Article  CAS  Google Scholar 

  7. Piazza, G.A. et al. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res. 57, 2909–2915 (1997).

    CAS  PubMed  Google Scholar 

  8. Elder, D.J.E., Halton, D.E., Hague, A. & Paraskeva, C. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin. Can. Res. 3, 1679–1683 (1997).

    CAS  Google Scholar 

  9. Vane, J. Towards a better aspirin. Nature 367, 215–216 (1994).

    Article  CAS  Google Scholar 

  10. Hong, S.H. et al. Regulation of head and neck tumor cell growth with cyclooxygenase-2 specific inhibitor, ketorolac. Cancer Res. 39, 196 (1998).

    Google Scholar 

  11. Hwang, D. et al. Expression of cyclooxygenase in human breast cancer. Cancer Res. 39, 353 (1998).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elder, D., Paraskeva, C. COX-2 inhibitors for colorectal cancer. Nat Med 4, 392–393 (1998). https://doi.org/10.1038/nm0498-392

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0498-392

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing